Search Site

Laval, QC, Canada

In 2009, Vertex established its Canadian research and development site in Laval, Quebec, Canada through the acquisition of ViroChem Pharma. Today, Vertex‚Äôs Laval scientists are focused on developing new approaches to the treatment of genetically associated renal diseases as well as cystic fibrosis.

Vertex Pharmaceuticals (Canada) Incorporated

Vertex Pharmaceuticals (Canada) Incorporated
275 Armand-Frappier
Laval (Quebec) H7V 4A7 Canada

Tel: 450-978-7700
Fax: 450-978-7972


Last updated: Thursday, February 2, 2017 - 16:11